Adjuvant Therapy for HER2-Positive Early Breast Cancer
Authors:
- 10 May 2016
- book chapter
- Published by Springer Nature
- p. 189-203
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- HER Story: The Next Chapter in HER-2-Directed Therapy for Advanced Breast CancerThe Oncologist, 2013
- Trastuzumab containing regimens for early breast cancerCochrane Database of Systematic Reviews, 2012
- Adjuvant Trastuzumab in HER2-Positive Breast CancerNew England Journal of Medicine, 2011
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized MedicineThe Oncologist, 2009
- Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsThe Oncologist, 2008
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Molecular portraits of human breast tumoursNature, 2000
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenNature, 1984